PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce that it has engaged Cannabis Compliance Inc. (CCI) to prepare the new Propagation Canada Services (PSC) cannabis propagation facility in Delta, BC. CCI has more than 10 years experience providing risk mitigation, due diligence and regulatory compliance to commercial cannabis producers and resellers worldwide.

“We are very pleased to be working with the team at PUF, the Houwelings Group and the recently formed Propagation Services Canada, as they introduce large-scale propagation services to the cannabis sector,” said Deepak Anand, Vice President of Business Development & Government Relations at Cannabis Compliance Inc. “This is one of the larger facilities that CCI has had the pleasure to work on and provide our regulatory expertise in preparation for Health Canada review. We have many clients who could benefit from this new propagation service to significantly increase revenue, protect intellectual property, reduce plant mortality and have a cleaner, safer and purer product for consumers.”


“I believe that an independent propagation services in the Canadian cannabis space, will massively disrupt cannabis growing methods in a very positive way,” said Derek Ivany, president and CEO of PUF Ventures. “Plant propagation is a scientific proposition requiring high tech labs and facilities, knowledgeable technicians and complex procedures to operate a successful operation. We are currently working with Casey to upgrade the existing greenhouses whereby PSC will supply flower-ready plants to growers and licensed producer and eliminate most of the technical risk of growing cannabis.”

As previously announced Propagation Services Canada was recently formed by PUF Ventures and Casey Houweling, a vegetable greenhouse grower with over 40 years of propagation growing experience. Houweling currently operates a large-scale vegetable propagation business with greenhouse propagation operations in a 2.2 million square foot facility located in Delta, British Columbia.  The facility is well suited to propagate flower-ready cannabis starter plants and will be the largest cannabis grower by number of plants in the world at a full capacity.

Propagation of cannabis plants is a highly technical and complicated process that can improve strain purity, eliminate contaminants and reduce diseases. By offering flower-ready plants to cannabis cultivators, growing operations are significantly simplified, the growing area allocated to harvest increased, resulting in meaningfully improved top line revenue and operating profits. PSC starter plants mitigate risk and allows cannabis cultivators to focus upon growing and processing flowering plants.

“The combination, of one of the most technically advanced greenhouse sites entering the cannabis industry and more than 40 years of propagation experience, is precisely what the cannabis industry requires to deliver clean, pure stock plants,” said Nico Hache, Cultivation Consultant at Cannabis Compliance Inc. “The nursery plant mortality rate in the industry is very high due to lack of facility and technical expertise to grow at scale. PSC has a facility, the technical expertise and with a few modifications will change the way cannabis is grown. This expertise is what has been missing in the industry and will be welcomed by licensed producer.”

About Cannabis Compliance Inc.

CCI, as one of Canada’s original cannabis consulting firms, offers risk mitigation, due diligence, and regulatory licensing consulting services for commercial cannabis producers and resellers. CCI has extensive expertise in cultivation/horticulture, security designs/tender, facility designs/build-outs, quality assurance programs, and financial planning. CCI has strategic partnerships globally to secure investment partners for its clients, general contractors for buildouts, security tenders, equipment suppliers, media, government relations, and enterprise resource planning software. For over a decade, CCI’s experienced team has been involved in commercial cannabis operations in Canada delivering proven results for their clients.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany
President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

Click here to connect with PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF) for an Investors Presentation

Source: www.newswire.ca

 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acb .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less